Applied DNA Sciences, Inc. (BNBX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Applied DNA Sciences, Inc. (BNBX) has a cash flow conversion efficiency ratio of -0.169x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.05 Million) by net assets ($12.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Applied DNA Sciences, Inc. fund operations to measure how many days the company can operate on defensive assets alone.
Applied DNA Sciences, Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Applied DNA Sciences, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Applied DNA Sciences, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Applied DNA Sciences, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Stellar AfricaGold Inc.
V:SPX
|
-0.152x |
|
Future PLC
LSE:FUTR
|
0.068x |
|
B90 HOLDINGS PLC
F:24GN
|
N/A |
|
Oblong Inc
NASDAQ:OBLG
|
-0.158x |
|
Willings Co. Ltd
KQ:313760
|
0.010x |
|
Xiwang Property Holdings Company Limited
F:XSA
|
0.000x |
|
Knosys Ltd
AU:KNO
|
-0.200x |
|
CPU Softwarehouse AG
F:CPU2
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Applied DNA Sciences, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Applied DNA Sciences, Inc. from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see Applied DNA Sciences, Inc. (BNBX) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $1.94 Million | $-12.52 Million | -6.447x | -321.69% |
| 2024-09-30 | $8.97 Million | $-13.71 Million | -1.529x | -19.81% |
| 2023-09-30 | $4.87 Million | $-6.22 Million | -1.276x | -83.51% |
| 2022-09-30 | $12.91 Million | $-8.98 Million | -0.695x | +42.28% |
| 2021-09-30 | $11.11 Million | $-13.39 Million | -1.205x | -- |
About Applied DNA Sciences, Inc.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic m… Read more